These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8061447)

  • 1. Repeat cerebral blood volume assessment with first-pass MR imaging.
    Runge VM; Kirsch JE; Wells JW; Dunworth JN; Hilaire L; Woolfolk CE
    J Magn Reson Imaging; 1994; 4(3):457-61. PubMed ID: 8061447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of cerebral perfusion by first-pass, dynamic, contrast-enhanced, steady-state free-precession MR imaging: an animal study.
    Runge VM; Kirsch JE; Wells JW; Woolfolk CE
    AJR Am J Roentgenol; 1993 Mar; 160(3):593-600. PubMed ID: 8430562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choice of metal ion and formulation concentration for first-pass brain perfusion studies with magnetic resonance imaging at 1.5 tesla.
    Runge VM; Wells JW
    Invest Radiol; 1996 Jul; 31(7):395-400. PubMed ID: 8818779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visualization of blood-brain barrier disruption on MR images of cats with acute cerebral infarction: value of administering a high dose of contrast material.
    Runge VM; Kirsch JE; Wells JW; Dunworth JN; Woolfolk CE
    AJR Am J Roentgenol; 1994 Feb; 162(2):431-5. PubMed ID: 8310940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detectability of small liver metastases with gadolinium BOPTA.
    Runge VM; Lee C; Williams NM
    Invest Radiol; 1997 Sep; 32(9):557-65. PubMed ID: 9291044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute stroke in cats: comparison of dynamic susceptibility-contrast MR imaging with T2- and diffusion-weighted MR imaging.
    Maeda M; Itoh S; Ide H; Matsuda T; Kobayashi H; Kubota T; Ishii Y
    Radiology; 1993 Oct; 189(1):227-32. PubMed ID: 8372198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrovascular transit characteristics of DyDTPA-BMA and GdDTPA-BMA on normal and ischemic cat brain.
    Kucharczyk J; Asgari H; Mintorovitch J; Vexler Z; Rocklage S; Watson A; Moseley M
    AJNR Am J Neuroradiol; 1993; 14(2):289-96. PubMed ID: 8456701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of cerebral diseases: how much contrast agent is enough? Comparison of 0.1, 0.2, and 0.3 mmol/kg gadoteridol at 0.2 T with 0.1 mmol/kg gadoteridol at 1.5 T.
    Brekenfeld C; Foert E; Hundt W; Kenn W; Lodeann KP; Gehl HB
    Invest Radiol; 2001 May; 36(5):266-75. PubMed ID: 11323514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echo-planar perfusion-sensitive MR imaging of acute cerebral ischemia.
    Kucharczyk J; Vexler ZS; Roberts TP; Asgari HS; Mintorovitch J; Derugin N; Watson AD; Moseley ME
    Radiology; 1993 Sep; 188(3):711-7. PubMed ID: 8351338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal metastasis. Detection and characterization on enhanced magnetic resonance imaging using an animal model.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1997 Apr; 32(4):212-7. PubMed ID: 9101356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of standard and high-dose contrast-enhanced breath-hold liver magnetic resonance for visualization of metastatic disease in an animal model.
    Runge VM
    Invest Radiol; 1998 May; 33(5):263-7. PubMed ID: 9609484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of bolus volume and dose of gadolinium chelate for first-pass myocardial perfusion MR imaging studies.
    Canet E; Douek P; Janier M; Bendid K; Amaya J; Millet P; Revel D
    J Magn Reson Imaging; 1995; 5(4):411-5. PubMed ID: 7549202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral hemodynamics and cerebral blood volume: MR assessment using gadolinium contrast agents and T1-weighted Turbo-FLASH imaging.
    Dean BL; Lee C; Kirsch JE; Runge VM; Dempsey RM; Pettigrew LC
    AJNR Am J Neuroradiol; 1992; 13(1):39-48. PubMed ID: 1595482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
    Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
    Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of regional cerebral blood volume in acute human stroke by use of single-slice dynamic susceptibility contrast-enhanced magnetic resonance imaging.
    Röther J; Gückel F; Neff W; Schwartz A; Hennerici M
    Stroke; 1996 Jun; 27(6):1088-93. PubMed ID: 8650719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early dynamic magnetic resonance imaging of liver metastases with 0.3 and 0.6 mmol/kg gadoteridol injection.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1996 Aug; 31(8):472-8. PubMed ID: 8854193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter-individual Comparison of Gadobutrol and Gadoteridol Tissue Time-intensity Profiles for Dynamic Susceptibility Contrast Perfusion MR Imaging.
    Yamada M; Taoka T; Kawaguchi A; Yasuda K; Niinomi Y; Ohashi Y; Okuda T; Naganawa S
    Magn Reson Med Sci; 2019 Jan; 18(1):75-81. PubMed ID: 29794406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion/perfusion MR imaging of acute cerebral ischemia.
    Kucharczyk J; Mintorovitch J; Asgari HS; Moseley M
    Magn Reson Med; 1991 Jun; 19(2):311-5. PubMed ID: 1881320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Brain magnetic resonance with magnetization transfer in multiple sclerosis. Lesion hyperintensity before and after intravenous gadolinium administration].
    Renzetti P; Parodi RC; Losacco C; Rosso E; Arcuri T; Sardanelli F
    Radiol Med; 1999 Sep; 98(3):138-43. PubMed ID: 10575442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consecutive acquisition of time-resolved contrast-enhanced MR angiography and perfusion MR imaging with added dose of gadolinium-based contrast agent aids diagnosis of suspected brain metastasis.
    Tsuchiya K; Aoki S; Shimoji K; Mori H; Kunimatsu A
    Magn Reson Med Sci; 2013; 12(2):87-93. PubMed ID: 23666159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.